BGM
Qilian International Holding Group LimitedNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$96.15M
P/E Ratio
—
EPS
$-0.16
Beta
1.46
52W High
$10.68
52W Low
$0.23
50-Day MA
$0.28
200-Day MA
$1.19
Dividend Yield
—
Profit Margin
-44.20%
Forward P/E
—
PEG Ratio
—
About Qilian International Holding Group Limited
Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company is headquartered in Jiuquan, the People's Republic of China.
Fundamentals
| Revenue (TTM) | $47.90M |
| Gross Profit (TTM) | $8.11M |
| EBITDA | $-9.25M |
| Operating Margin | -3.61% |
| Return on Equity | -7.41% |
| Return on Assets | -2.18% |
| Revenue/Share (TTM) | $0.25 |
| Book Value | $1.99 |
| Price-to-Book | 0.26 |
| Price-to-Sales (TTM) | 2.01 |
| EV/Revenue | 1.914 |
| EV/EBITDA | -2.48 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 69.80% |
| Shares Outstanding | $380.62M |
| Float | $133.30M |
| % Insiders | 38.05% |
| % Institutions | 0.10% |
Historical Volatility
HV 10-Day
42.17%
HV 20-Day
89.62%
HV 30-Day
85.85%
HV 60-Day
88.10%
HV Rank
—
Volatility is currently contracting
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on BGM and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 9/26/2026